Ashley Mark Hopkins
Flinders University
H-index: 20
Oceania-Australia
Top articles of Ashley Mark Hopkins
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Association of proton pump inhibitor use with survival and adverse effects outcomes in patients with multiple myeloma: pooled analysis of three clinical trials | Scientific Reports | Sara A Almansour Mohammad AY Alqudah Ziad Abuhelwa Humaid O Al-Shamsi Mohammad H Semreen | 2024/1/5 |
Current safeguards, risk mitigation, and transparency measures of large language models against the generation of health disinformation: repeated cross sectional analysis | bmj | Bradley D Menz Nicole M Kuderer Stephen Bacchi Natansh D Modi Benjamin Chin-Yee | 2024/3/20 |
Special Paper: Current safeguards, risk mitigation, and transparency measures of large language models against the generation of health disinformation: repeated cross sectional … | The BMJ | Bradley D Menz Nicole M Kuderer Stephen Bacchi Natansh D Modi Benjamin Chin-Yee | 2024 |
Accessibility of clinical study reports supporting medicine approvals: a cross-sectional evaluation | Journal of Clinical Epidemiology | Ashley M Hopkins Natansh D Modi Frank W Rockhold Tammy Hoffmann Bradley D Menz | 2024/3/1 |
Health disinformation use case highlighting the urgent need for artificial intelligence vigilance: weapons of mass disinformation | JAMA internal medicine | Bradley D Menz Natansh D Modi Michael J Sorich Ashley M Hopkins | 2024/1/1 |
Potential of Large Language Models as Tools Against Medical Disinformation—Reply | JAMA Internal Medicine | Ashley M Hopkins Bradley D Menz Michael J Sorich | 2024/2/26 |
Exploring the role of sporadic BRAF and KRAS mutations during colorectal cancer pathogenesis: A spotlight on the contribution of the endosome-lysosome system | Jingying Tang Giang T Lam Robert D Brooks Mark Miles Zivile Useckaite | 2024/1/28 | |
Comparative risk of gout flares when initiating or escalating various urate-lowering therapy: a systematic review with network meta-analysis | Dorsa Maher Emily Reeve Ashley Hopkins Jiun Ming Tan Mahsa Tantiongco | 2024/2/1 | |
A lack of association between BMI and chemoimmunotherapy efficacy in advanced non-small cell lung cancer: Secondary analysis of the IMpower150 and IMpower130 clinical trials | BMC cancer | Lee X Li Mark A Socinski Ganessan Kichenadasse Christos S Karapetis Adel Shahnam | 2024/3/25 |
Objective response rate and progression-free survival as surrogates for overall survival treatment effect: A meta-analysis across diverse tumour groups and contemporary therapies | European Journal of Cancer | Adel Shahnam Nadia Hitchen Udit Nindra Sathya Manoharan Jayesh Desai | 2024/2/1 |
Quality and safety of artificial intelligence generated health information | BMJ | Michael J Sorich Bradley D Menz Ashley M Hopkins | 2024/3/20 |
Is there a harmonised standard to oncology trial data provision in data sharing initiatives? | Ashley Mark Hopkins Natansh Modi Michael J Sorich | 2023/6/1 | |
A 10-year update to the principles for clinical trial data sharing by pharmaceutical companies: perspectives based on a decade of literature and policies | BMC medicine | Natansh D Modi Ganessan Kichenadasse Tammy C Hoffmann Mark Haseloff Jessica M Logan | 2023/10/23 |
Aberrant protein expression of Appl1, Sortilin and Syndecan-1 during the biological progression of prostate cancer | Pathology | Carmela Martini Jessica M Logan Alexandra Sorvina Colin Gordon Andrew R Beck | 2023/2/1 |
Association between patient-reported outcomes and therapeutic outcomes in patients with breast cancer: A pooled individual-participant data analysis. | Natansh Modi Ahmad Y Abuhelwa Andrew Rowland Bradley D Menz Ross Allan McKinnon | 2023/6/1 | |
231P Time to deterioration of quality of life as a surrogate of OS: A trial-level surrogacy analysis | Annals of Oncology | A Shahnam U Nindra J Desai R Hui AM Hopkins | 2023/10/1 |
Female reproductive status and exogenous sex hormone use in rheumatoid arthritis patients treated with tocilizumab and csDMARDs | Rheumatology | Dala N Daraghmeh Ashley M Hopkins Catherine King Ahmad Y Abuhelwa Mihir D Wechalekar | 2023/2/1 |
Low risk of hyperprogression with first-line chemoimmunotherapy for advanced non-small cell lung cancer: pooled analysis of 7 clinical trials | The oncologist | Lee X Li Federico Cappuzzo Ignacio Matos Mark A Socinski Ashley M Hopkins | 2023/4/1 |
Insights into Melanoma Clinical Practice: A Perspective for Future Research | Cancers | Giang T Lam Carmela Martini Tiffany Brooks Sarita Prabhakaran Ashley M Hopkins | 2023/9/19 |
Artificial intelligence chatbots will revolutionize how cancer patients access information: ChatGPT represents a paradigm-shift | JNCI Cancer Spectrum | Ashley M Hopkins Jessica M Logan Ganessan Kichenadasse Michael J Sorich | 2023/4/1 |
Co-Authors
